[Impact of novel P2Y12 receptor inhibitors on platelet reactivity in acute coronary syndrome patients undergoing percutaneous coronary intervention].


OBJECTIVE To investigate the impact of novel P2Y(12) receptor inhibitors including prasugrel or ticagrelor on platelet reactivity in patients with acute coronary syndrome (ACS) receiving percutaneous coronary intervention (PCI), and provide clinical data for novel oral P2Y(12) receptor inhibitors use among Chinese patients. METHODS Between October 2011 to… (More)
DOI: 10.3760/cma.j.issn.0253-3758.2016.02.011


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics